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Abstract
Unselected population-based nationwide studies on the excess mortality of individuals with
severe mental disorders are scarce with regard to several important causes of death. Using
comprehensive register data, we set out to examine excess mortality and its trends among
patients with severe mental disorders compared to the total population. Patients aged 25–
74 and hospitalised with severe mental disorders in 1990–2010 in Finland were identified
using the national hospital discharge register and linked individually to population register
data on mortality and demographics. We studied mortality in the period 1996–2010 among
patients with psychotic disorders, psychoactive substance use disorders, and mood disor-
ders by several causes of death. In addition to all-cause mortality, we examined mortality
amenable to health care interventions, ischaemic heart disease mortality, disease mortality,
and alcohol-related mortality. Patients with severe mental disorders had a clearly higher
mortality rate than the total population throughout the study period regardless of cause of
death, with the exception of alcohol-related mortality among male patients with psychotic
disorders without comorbidity with substance use disorders. The all-cause mortality rate
ratio of patients with psychotic disorders compared to the total population was 3.48 (95%
confidence interval 2.98–4.06) among men and 3.75 (95% CI 3.08–4.55) among women in
the period 2008–10. The corresponding rate ratio of patients with psychoactive substance
use disorders was 5.33 (95% CI 4.87–5.82) among men and 7.54 (95% CI 6.30–9.03)
among women. Overall, the mortality of the total population and patients with severe mental
disorders decreased between 1996 and 2010. However, the mortality rate ratio of patients
with psychotic disorders and patients with psychoactive substance use disorders compared
to the total population increased in general during the study period. Exceptions were alco-
hol-related mortality among patients with psychoactive substance use disorders and female
patients with psychotic disorders, as well as amenable mortality among male patients with
psychotic disorders. The mortality rate ratio of persons with mood disorders compared to
the total population decreased. The markedly high mortality amenable to health care inter-
vention among patients with severe mental disorders found in our study suggests indirectly
that they may receive poorer quality somatic care. The results highlight the challenges in
co-ordinating mental and somatic health services.
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Introduction
Research has repeatedly shown disparities in health and health care between those with mental
disorders and the general population. Individuals with severe mental disorders (SMD) have
greater mortality and increased risk of premature death [1, 2]. Individuals suffering from any
of the common mental disorders, especially persons with psychotic disorders, major depressive
disorders, and substance use disorders, have increased risk of premature death. The risk is not
similar for all mental health problems and the underlying causes of death may also vary [3, 4].
Patients with psychotic disorders are also highly comorbid with alcohol and other substance
abuse disorders [5, 6]. Psychiatric patients comorbid with substance use disorders have a
higher risk of mortality than psychiatric patients without substance use disorders according to
earlier studies [3, 7].
Higher risk of suicides, unintentional injuries, less healthy lifestyles, poorer socioeconomic
circumstances, adverse metabolic effects of antipsychotic medications, and social consequences
of mental illness have been found to partly explain these findings [3, 8, 9]. The excess mortality
is also a consequence of increased risk of comorbid somatic illnesses and higher case-fatality
among persons with SMDs [3, 10].
Despite reforms in mental health services, the mortality gap has remained in many Western
countries, which generally have well-functioning health systems [11–13]. An important factor
contributing to this gap is also poorer access to and quality of somatic care [1, 3, 14, 15]. Study-
ing amenable deaths provides information that can be used to evaluate health care perfor-
mance. Amenable mortality captures premature deaths that would have been prevented by
timely and effective health care intervention and is increasingly used as an indicator of the
effectiveness of health care [16]. Mortality amenable to medical intervention consists of
selected causes of deaths, focusing on conditions for which effective clinical interventions exist
generally in people aged less than 75 years. Age limits vary for some diseases due to the fact
that health care may not be able to contribute substantially to survival above or below a certain
age. This definition of amenable mortality was first proposed 40 years ago by Rutstein et al.
(1976) and has been adopted and modified in several studies [16–18].
Several studies have examined excess amenable mortality among psychiatric patients in dif-
ferent study settings, suggesting that somatic care provided to patients with mental illnesses is
less adequate than for the population in general [3, 19–21]. Although earlier studies address
excess mortality in patients with SMDs, representative/unselected population-based nation-
wide studies are scarce in regard to several important causes of death, such as alcohol-related
deaths and amenable deaths. In addition, there is a gap in the literature when it comes to focus-
ing on time trends in excess mortality.
Thus, using comprehensive register data, we aim to examine excess mortality and its trends
among patients with SMDs in Finland in 1996–2010 compared to the total population. Mortal-
ity among patients hospitalised due to psychotic disorders, psychoactive substance use disor-
ders and mood disorders is studied by several causes of death groups. Our aim is also to assess
the quality of somatic care provided to patients with SMDs by using mortality amenable to
health care as an indicator.
Material and Methods
Data
The cohort of patients with severe mental disorders aged 25–74 was defined as those hospital-
ised at least once with the main diagnosis being a psychotic disorder (ICD-10: F20-F29), a psy-
choactive substance use disorder (F10-F19), or a mood disorder (F30-F39) during the period
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1990–2010 in Finland and alive on January 1st 1996. The hospitalisations were identified using
the national hospital discharge register, which includes all hospital admissions in Finland. The
data on hospital care were individually linked to the population registers of Statistics Finland
for mortality data and demographic factors for the years 1996–2010. The study protocol was
approved by the Ethical Review Board of the National Institute for Health andWelfare. Per-
mission to use the above-described register data was obtained from the competent authorities.
The data compilation was conducted by the competent authorities, with the study group
receiving anonymised data.
SMD categories
The study population consists of all non-institutionalised patients with SMDs and resident in
Finland. Persons aged over 25 years remain in the study population while aged under 75 years
and until the end of the study period, death or moving to another SMD category. We divided
the cohort of patients with SMDs into three diagnosis categories: 1) psychotic disorders (PD),
2) psychoactive substance use disorders (PSD), and 3) mood disorders (MD) and analysed the
data in these categories due to the different nature of the mental disorders in question. Using
the same hierarchical rule as in an earlier Finnish study [22], we categorised the individual as a
patient with a psychotic disorder if he/she had been hospitalised with a PD in addition to either
of the two other disorders. Following this rule further, an individual with a hospitalisation due
to both a PSD and a MD was categorised as a patient with PSD. Thus, the patients with MDs in
our study did not have any record of PDs or PSDs. Patients were defined as belonging to the
category from the first admission date for the diagnosis at issue. Patients with PDs and who
were comorbid with any of the other SMDs in question belonged into the PSD or MD category
until the first admission due to PD and remained in the PD category until the end of the fol-
low-up. The total non-institutionalised Finnish population aged 25–74 in 1996–2010 was used
as the comparison group. The data were analysed as tabulated, i.e. the number of deaths by per-
son years in the follow-up of the corresponding population (SMD category or total population)
by five-year age groups and gender.
Mortality groups
We studied excess mortality among patients with SMDs compared to the total population in
1996–2010. In addition to all-cause mortality, we classified mortality into sub-groups: mortal-
ity amenable to health care interventions, ischaemic heart disease (IHD) mortality, disease
mortality, and alcohol-related mortality (See Table 1 for a list of causes of death). In this study
the selection of causes of death considered amenable to health care was modified from classifi-
cations used by Nolte and McKee (2008) and Page et al. (2006) [18, 23]. Those underlying
causes of death caused directly by excess alcohol consumption or diseases caused by excess
alcohol consumption where defined as alcohol-related deaths. The sub-groups are not, how-
ever, totally exclusionary. For example, IHD deaths are included in the disease mortality group.
Statistical methods
To study the overall level of mortality in Finland, we calculated annual age-standardised mor-
tality rates per 100 000 person years among the total population in 1996–2010 by cause-of-
death groups. We used the direct method of standardisation and as the standard population we
used the non-institutionalised Finnish population in 2010. To ensure a sufficient number of
events in each age-stratum and to avoid random variation, we combined the annual data into
five three-year periods (1996–98, 1999–2001, 2002–04, 2005–07, and 2008–10) when studying
the excess mortality of the patients with SMDs by categories. The excess mortality was then
Excess Mortality in Patients with Mental Disorders
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Table 1. List of causes of death.
Cause of death group ICD-10
Disease mortality A00- R99, excl. R999
Ischaemic heart disease mortality I20–25
Alcohol-related mortality
Mental and behavioural disorders due to psychoactive use substance
use
F10
Degeneration of nervous system due to alcohol G31.2
Epileptic seizures related to alcohol G40.51
Alcoholic polyneuropathy G62.1
Alcoholic myopathy G72.1
Alcoholic cardiomyopathy I42.6
Alcoholic gastritis K29.2
Alcoholic liver disease K70
Alcohol induced acute pancreatitis K85.2, K86.0
Maternal care for (suspected) damage to fetus from alcohol O35.4
Fetus and newborn affected by maternal use of alcohol P0.43
Fetal alcohol syndrome (dysmorphic) Q86.0
Accidental poisoning by and exposure to alcohol X45
Mortality amenable to health care interventions Agea
Diphtheria, Tetanus, Poliomyelitis, and Varicella A35–36, A80, B01 1–74
Rubella B06 1–74
Scarlatina A38 1–74
Meningococcus A39 1–74
Erysipelas A46 1–74
Legionellosis A48.1 1–74
Malaria B50–54 1–74
Streptococcal pharyngitis J02.0 1–74
Cellulitis L03 1–74
Tuberculosis A15–19, B90 1–74
Malignant neoplasm of colon and rectum C18–21 1–74
Melanoma of skin C43 1–74
Malignant neoplasm of skin C44 1–74
Malignant neoplasm of breast C50 1–74
Malignant neoplasm of cervix uteri C53 1–74
Malignant neoplasm of cervix uteri and body of uterus C54–55 1–44
Malignant neoplasm of bladder C67 1–74
Benign tumors D10–36 1–74
Hypertensive disease I10–13, I15 1–74
Cerebrovascular disease I60–69 1–74
Diseases of the thyroid E00–07 1–74
Diabetes mellitus E10–14 1–49
Epilepsy G40–41 1–74
Asthma J45–46 15–
49
COPD J40–44 15–
49
Septicaemia A40–41 1–74
Malignant neoplasm of testis C62 1–74
Hodgkin’s disease C81 1–74
(Continued)
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estimated using the rate ratio (RR) approach by comparing mortalities in the three SMD cate-
gories with mortality in the total population. The 95% confidence intervals for the rate ratio of
two standardised rates were estimated using Gaussian approximation [24].
We performed additional analyses for persons with PDs and excluded patients comorbid
with PSD admissions, since persons with PDs are highly comorbid with alcohol and other sub-
stance abuse disorders, which of itself also increases the risk of premature death.
Furthermore, we conducted sensitivity analyses for the mortality rate ratios for patients
with SMDs versus the total population by including only patients with hospitalisations due to
SMDs from a preceding period of five years or during the particular study year. This enabled
us to study whether the longer follow-up times for the later study periods had an influence on
the results.
SAS (SAS Institute Inc., Cary, NC, USA) version 9.3 was used in these analyses.
Results
Background characteristics
The average annual number of person years in the study period for the non-institutionalised
total population aged 25–74 was about 1 598 000 among men and 1 637 000 among women.
The proportion of the patient cohort hospitalised due to severe mental health disorders of the
total population was 4% among men and 3% among women in 1996 and was somewhat higher
in 2010. The majority (over 50%) of male patients with SMDs were categorised as patients with
PSDs, and the majority of female patients with SMDs were categorised as patients with PDs
according to our definitions (Table 2). During the study period, the proportions of male
patients with PDs and PSDs had decreased somewhat and the proportion of MDs had
increased from 14% to 23%. Among women, the proportion of patients with PDs had clearly
decreased (from 49% to 34%), while the proportion of MDs had increased from 30% to 43%. In
1996, 63% of all male patients with SMDs had hospitalisations due to PSDs and in 2010 the
proportion was 57%, whereas among female patients this proportion was much less, at 26%
both in 1996 and 2010. Among male patients with PDs, 23% also had hospitalisations due to
Table 1. (Continued)
Cause of death group ICD-10
Leukaemia C91–95 1–44
Rheumatic and other valvular heart disease I01–09 1–74
Inﬂuenza J09–11 1–74
Pneumonia J12–18 1–74
Peptic ulcer K25–28 1–74
Appendicitis K35–38 1–74
Abdominal hernia K40–46 1–74
Cholelithiasis and cholecystitis K80–81 1–74
Nephritis, nephrosis, and nephropathy N00–09, N17–19, N25–
27
1–74
Obstructive uropathy and prostatic hyperplasia N13, N20–21, N35, N40 1–74
Maternal death O00–O99 All
Congenital cardiovascular anomalies Q20–Q28 1–74
a Age restrictions are only for mortality amenable to health care interventions. In our study, deaths of
people aged under 25 years were excluded from the analyses.
doi:10.1371/journal.pone.0152223.t001
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PSDs in 1996 and slightly less in 2010. Among female patients with psychotic disorders, the
proportion of hospitalisations due to PSDs was much lower than among male patients, at less
than 10% in both years.
Mortality rates
Fig 1 presents age-standardised mortality rates (/100 000 person years) by cause-of-death
groups among the total population and patients with SMDs aged 25–74 by cause-of-death
groups for the period 1996–2010 in Finland. In 1996, the all-cause mortality rate among the
total population was 980 among men and 420 among women and decreased by 30% (men) and
20% (women) during the study period (p-values for linear trend = 0.001). The mortality trends
for all causes-of-death sub-groups were downward (p = 0.001) except for alcohol-related mor-
tality, which increased from 68 to 81 among men and from 13 to 23 among women
(p = 0.001). Similarly, mortality among patients with SMDs decreased regardless of cause of
death (p = 0.001), except for alcohol-related mortality, which increased (p = 0.052 for men,
p = 0.007 for women). The all-cause mortality rate among patients with SMDs was 3500
among men and 1700 among women in 1996 and decreased by 20% (men) and 25% (women)
in the study period. When studying the SMD categories separately, differences were found in
alcohol-related mortality, which increased significantly only among male patients with PDs
(p = 0.001). Among female patients with PDs and all patients with PSDs the increasing trend
was not statistically significant (p> 0.05). Among male patients with MDs, alcohol-related
mortality decreased significantly (p = 0.014), but among female patients with MDs the decreas-
ing trend was not significant (p = 0.837).
Table 2. Number of person years (py) for the total population and for patients with severe mental disorders (SMD), non-institutionalised and aged
25–74, the proportion of patients with SMDs by hierarchical categories (patients with psychotic disorders [PD], psychoactive substance use disor-
ders [PSD] or mood disorders [MD]), and the proportion of patients with hospitalisations due to PSDs by gender in 1996 and 2010 in Finland.
MEN
year 1996 year 2010
Total population SMD ! 63% PSD Total population SMD ! 57% PSD
py 1,564,800 57,500 1,650,100 91,400
.#& .#&
PD PSD MD PD PSD MD
30% 56% 14% 25% 52% 23%
# #
23% also PSD 19% also PSD
WOMEN
year 1996 year 2010
Total population SMD ! 26% PSD Total population SMD ! 26% PSD
py 1,623,300 40,600 1,677,900 71,800
.#& .#&
PD PSD MD PD PSD MD
49% 21% 30% 34% 23% 43%
# #
9% also PSD 9% also PSD
.#& Categorised according to the hierarchial rules described in the Manuscript.
! Proportion of patients hospitalised with PSDs among patients with SMDs.
# Proportion of patients hospitalised with PSDs among patients with PDs.
doi:10.1371/journal.pone.0152223.t002
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Excess mortality
Next we studied the excess mortality in patients with SMDs compared to the total population
by disease categories in five three-year periods (Fig 2). The change in the excess mortality was
mainly linear, thus we present results only for the first and the last study periods. Generally,
women had higher excess mortality estimated with the rate ratios of age-standardised mortality
rates (RR).
Patients with psychotic disorders
The excess mortality among patients with PDs was statistically significant in all causes-of-death
groups, except that the RR for alcohol-related mortality was not significant in the period 1996
to 2004 among men. The excess mortality increased during the study period with the exception
of amenable mortality among men and alcohol-related mortality among women. In the period
2008–10, the RR for all-cause mortality was 3.48 (95% confidence interval 2.98–4.06) among
men and 3.75 (95% CI 3.08–4.55) among women (Fig 2).
Patients with psychoactive substance use disorders
In general, patients with PSDs had the highest excess mortality of the three SMD categories
(Fig 2). Even though the alcohol-related excess mortality decreased during the study period, it
was especially high throughout the study period and the RR was as high as 13.30 (95% CI
Fig 1. Age-standardisedmortality rates (/100 000 person years) among the total population and patients with severemental disorders (SMD) by
gender and cause-of-death groups for the period 1996–2010 in Finland. The data for Fig 1 are available in S1 Dataset.
doi:10.1371/journal.pone.0152223.g001
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11.30–15.70) among men and 35.80 (95% CI 25.80–49.70) among women in 2008–10. The
excess mortality increased in all the other causes of death groups during the study period. In
2008–10, the RR for all-cause mortality was 5.33 (95% CI 4.87–5.82) among men and 7.54
(95% CI 6.30–9.03) among women.
Patients with mood disorders
Patients with MDs had the lowest excess mortality among both genders (Fig 2). In general, the
excess mortality in patients with MDs decreased in the period 1996 to 2010. Especially, alco-
hol-related mortality decreased from 2.34 (95% CI 1.09–5.02) to 1.24 (95% CI 0.62–2.46)
among men. In 2008–10, the RR for all-cause mortality was 2.14 (95% CI 1.75–2.61) among
men and 2.30 (95% CI 1.84–2.88) among women.
Sensitivity analyses
The sensitivity analyses yielded systematically higher rate ratios for the mortality differences
between patients with SMDs and the total population compared to the original RRs in each
Fig 2. The rate ratios (RR) of the excessmortality in patients with severe mental disorders (SMD) compared to the total population by gender,
cause-of-death groups, and the SMD categories (patients with psychotic disorders [PD], psychoactive substance use disorders [PSD], andmood
disorders [MD]) in the periods 1996–98 and 2008–10 in Finland. (A) The alcohol-related mortality RR was 15.18 (95% confidence interval 12.16–18.96) in
the period 1996–98 and 13.30 (95%CI 11.28–15.69) in the period 2008–10. (B) The alcohol-related mortality RR was 54.79 (95% CI 34.22–87.71) in the
period 1996–98 and 35.78 (95% CI 25.76–49.71) in the period 2008–10. Non-significant RRs indicated as NS. The data for Fig 2 in addition to the data for the
other study periods and all 95% confidence intervals are available in S2 Dataset.
doi:10.1371/journal.pone.0152223.g002
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three-year-period. In these analyses we included only patients with hospitalisations due to
SMDs from a preceding period of five years or during the particular study year. Only RRs for
alcohol-related mortality in three study periods among women were found to be somewhat
lower compared to the original RRs. The data for the sensitivity analyses are available in S3
Dataset.
Impact of hospitalisations due to PSDs among patients with psychotic
disorders
We also studied the impact of hospitalisations due to PSDs on the excess mortality among
patients with PDs (Fig 3). We found that among patients with co-existing PSD, only alcohol-
related mortality was significantly higher compared to patients without PSDs among patients
with PDs in 1996–98. The alcohol-related mortality rate was 5.70-fold higher (95% CI 1.46–
22.26) among men and 22.87-fold higher (95% CI 3.18–164.66) among women with co-exist-
ing PSD in 1996–98. On the other hand, IHD mortality was higher among male patients with-
out PSDs and amenable mortality was higher among female patients without PSDs in 1996–98.
During the study period the differences increased somewhat and in 2008–10 also disease and
all-cause mortality were significantly higher for those with comorbidity with PSD among men.
Among women, all-cause mortality became significantly higher by 2008–10 for those with co-
existing PSDs. Among them, differences in alcohol-related mortality decreased, but the RR
remained still notably high, at 11.36 (95% CI 3.18–164.66). Throughout the study period alco-
hol-related mortality was even lower among male patients with PDs without comorbidity with
PSD compared to the total male population, but the differences were not statistically
significant.
Discussion
Our study showed that compared to the overall population in Finland the patients with severe
mental disorders have clearly higher mortality regardless of cause of death, with the exception
of male patients with psychotic disorders without comorbidity with psychoactive substance use
Fig 3. The rate ratios (RR) of the excessmortality in patients with psychotic disorders (PD) comorbid with psychoactive substance use disorders
(PSD) compared to patients with PDs without PSDs by gender and cause-of-death groups in the periods 1996–98 and 2008–10 in Finland. (a) The
alcohol-related mortality RR was 5.70 (95% confidence interval 1.46–22.26) in the period 1996–98 and 11.44 (95% CI 3.81–34.22) in the period 2008–10. (b)
The alcohol-related mortality RR was 22.87 (95%CI 3.18–164.66) in the period 1996–98 and 11.36 (95% CI 2.64–48.84) in the period 2008–10. Significant
RRs indicated as *. The data for Fig 3 in addition to the data for the other study periods and all 95% confidence intervals are available in S4 Dataset.
doi:10.1371/journal.pone.0152223.g003
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disorders. We studied the excess mortality by three common SMD categories: psychotic disor-
ders, psychoactive substance use disorders, and mood disorders. In general, patients with PSDs
had the highest excess mortality according to our findings, which is in line with earlier studies
[3]. In addition to the excess all-cause mortality, we examined the excess mortality in several of
the causes-of-death sub-groups in which previous studies have found high mortality among
patients with SMDs. Earlier studies, however, have not examined in detail the excess alcohol-
related mortality (not only cirrhosis) of patients with SMDs. Our study also adds to the litera-
ture by exploring trends in the excess mortality in Finland using a population-based dataset
covering a long time period. During the study period 1996–2010 there was a clear decrease in
all-cause mortality in the total population and in patients with SMDs. However, we found that
the relative differences between patients with the most severe forms of mental disorders, PDs
and PSDs, increased compared to the total population, while the excess mortality of persons
with MDs somewhat decreased.
In the current study, the excess mortality in patients hospitalised with SMD was found to be
systematically pronounced throughout the long study period and for each cause-of-death
group. As noted in other studies, this finding is likely to partly reflect differences in health
behaviours. Patients with mental disorders have higher smoking rates, poorer diet, are less
physical active, and suffer more from obesity than the general population [25]. One notable
risk factor concerning health behaviours is heavier use of alcohol and drugs, which was also
found in our study; about 60% of the studied male patients and a quarter of the female patients
with SMDs had hospitalisations due to substance abuse. The most serious consequence of sub-
stance abuse was clearly seen from our results: among patients with PSDs the excess mortality
was notably high in each cause-of-death group. Even though substance abuse was much more
common among men than among women, alcohol-related mortality as a consequence of abuse
was substantially high among female patients with PDs or PSDs.
Psychiatric patients comorbid with a substance use disorder have a higher risk of mortality
than psychiatric patients without a substance use disorder according to earlier studies [3, 7].
Thus, we also explored the impact of comorbidity with PSD on the excess mortality of patients
with psychotic disorders. We found that comorbidity with PSD had a strong influence only on
alcohol-related mortality among patients with PDs. In some study periods it also had a signifi-
cant, but rather weak effect on disease mortality. Interestingly, male patients with PDs without
comorbidity with PSDs had even lower alcohol-related mortality than the total population
throughout the study period (the differences were not, however, statistically significant). It is
possible that among at least certain sub-populations without a comorbid PSD, alcohol use pat-
terns are not particularly hazardous or risky. Among persons with severe mental illness, deficits
in executive functioning may protect from impulsive alcohol use patterns. Differences in all-
cause mortality in the later years of the study period were explained by differences in alcohol-
related mortality among both genders.
The excess mortality of patients hospitalised with SMDs is also likely to partly reflect differ-
ences in poorer physical health; among patients with psychosis this often occurs at an early
age. Many chronic diseases, such as diabetes, acute respiratory disorders, and asthma, are com-
mon among the mentally ill. In particular, several studies have shown a high prevalence of car-
diovascular diseases among patients with psychosis [26, 27]. The explanations for elevated risk
for morbidity are complex and interconnected, and relate to a range of external influences of
both risk and (a lack of) protective factors. For example, social exclusion and lack of social net-
works, which are also risk factors for poorer physical health, are common among patients with
SMDs. According to our findings, excess disease mortality was systematically and significantly
high among both genders, which is obviously caused by higher chronic disease prevalence
among patients with SMDs. Moreover, the excess IHD mortality was notably high among
Excess Mortality in Patients with Mental Disorders
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female patients with PDs or PSDs. Lawrence et al., Kisely et al., and Manderbacka et al., for
example, suggest an explanation for the excess IHD mortality: Patients with SMDs may suffer
from lower quality of and poorer access to treatment of cardiovascular diseases [14, 19, 22].
The excess mortality of patients with SMDs is undoubtedly also a consequence of differ-
ences in care seeking for somatic diseases. However, since this patient group is already in touch
with health services (at least in settings where the patient group is identified from hospital reg-
isters) due to their mental health problems, it may also partly reflect the availability and quality
of somatic health services. During the 1990s and early 2000s a large part of mental health ser-
vices were administratively transferred to health centres and many long-term patients were
transferred from hospital care to outpatient care or to transitional services, e.g. supported hous-
ing in Finland. Institutional care is provided in the psychiatric units of hospitals and while
some of the units are physically located in general hospitals, some are separate psychiatric hos-
pitals [28]. In these separate hospital settings, patients with SMDs may have some difficulties
accessing adequate somatic care and their somatic symptoms may not be recognised.
Disparities in amenable mortality are used as a warning signal for the quality of care. Ring-
bäck Weitoft et al. were one of the first research groups to study excess amenable mortality
among psychiatric patients compared to the general population [29]. They found markedly ele-
vated risks for the period 1986–90. Several studies using different settings and classifications
have since concordantly reported increased risk of amenable mortality for psychiatric patients
[3, 20, 21]. The main results of the current study are in line with this finding. However, one
notable result in our study was that the excess amenable mortality of female patients with PDs
comorbid with PSDs compared to the total female population was not significant in 1996–98,
but increased later and was about five times higher in all the other study periods.
Regarding the decreasing excess mortality among the MD category, a relative change in the
characteristics of MD patients treated in hospital is possible given the overall shortened treat-
ment periods and more numerous kinds of inpatients [30]. This may include more patients
with lower risk for diseases and death. Another explanation could be improved management of
depression, which is supported by a remarkable decrease in suicide mortality in Finland within
the last decades.
We also conducted sensitivity analyses for the excess mortality rate ratios by including only
patients with hospitalisations due to SMDs from a preceding period of five years or during the
follow-up year. These sensitivity analyses yielded systematically higher rate ratios. In addition,
the rate ratios of the sensitivity analyses were consistently higher throughout the study period
compared to the original results. The results corroborated with our main findings. These sensi-
tivity analyses enabled us to assure that the definition of the cohort and cumulating follow-up
time did not affect the results. Severe mental disorders have often long natural courses, thus the
results are not sensitive to the definition of the population at risk, as can be seen from our
results.
Health register data in Finland are of high quality in general [31]. Thus, a major strength of
our study is that we were able to use individual-level register data on hospital use among all
Finnish residents aged 25 to 74 years from a 21-year period linked with the causes-of-death sta-
tistics. The accuracy and coverage of the Hospital Discharge Register has been reported to be
generally good [32]. Also, Finnish data on mortality are comprehensive due to the complete-
ness of death registration, the process for expert review of disputed cases, and the high autopsy
rate for deaths from suspicious and external causes [33].
Amenable mortality is a crude indicator of access to care; thus the results should be inter-
preted with caution. While the strength of amenable mortality is that it relies on a list of condi-
tions in which death could be avoided by identifiable effective interventions in health care, it
simultaneously sums up death rates from a long list of diseases, some of which have a negligible
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contribution to amenable mortality. The mortality of patients hospitalised due to mental health
disorders compared to mental health outpatients is higher. Consequently, our results may not
be applicable to all individuals with mental health disorders. In addition, we were not able to
study suicides separately.
Conclusions
Studying mortality rates and the excess mortality of patients hospitalised with SMDs may
reflect the availability of health services, since this patient group is already in touch with health
services due to their mental health problems. Our results of notably high excess amenable mor-
tality among patients with SMDs suggest indirectly that patients with SMDs are less likely to
receive good quality somatic care. In addition to the unsatisfactory treatment of somatic care,
the results highlight the challenges of organising health services. In light of our findings, a bet-
ter integration of psychiatric and somatic services, as well as substance use and health services
seems justified. Moreover, the excess mortality has increased over time, suggesting that patients
with SMDs have not benefited from improvements in health care to the same extent as the gen-
eral population. The results on increasing avoidable mortality among women in Finland sug-
gest a deterioration in access to and/or the quality of somatic health services for patients with
serious mental disorders over the last 20 years. Somatic diseases in mental health patients
should be more carefully taken into account when designing mental and somatic health care
services.
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